Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Discover the Witchery White Shirt Campaign 2025 in collaboration with Viktoria & Woods founder, Margie Woods, for ovarian ...

Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

Researchers believe that Semaglutide shows promise in cutting the risk of conditions that could impair memory and thought ...

The UCSF luminary and recipient of the prestigious award has played a pivotal part in identifying the cause of multiple sclerosis, leading to a new generation of game-changing therapies.

Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the ...

Cells throughout the body work together like singers in a choir to keep us healthy, as long as they work in perfect harmony.

Dozens of trials testing GLP-1 drugs like semaglutide, the medicine in Ozempic and Wegovy, against a placebo suggest that ...

From AI-powered scribes and predictive analytics to cellular therapy breakthroughs and hospital redesigns, leaders from Fortune’s most innovative health systems share the transformative changes ...

Citi analyst Patrick Donnelly lowered the firm’s price target on Icon (ICLR) to $215 from $290 and keeps a Buy rating on the shares as part of ...

Long COVID advocates and researchers in the United States have done the extraordinary. After a bruising battle, they managed ...

For both of us, these weren’t just personal battles — they were fights made possible by biomedical research. The government’s ...